Tilray Brands, Inc. Repayments of Convertible Debt
Tilray Brands, Inc. (TLRY) reported Repayments of Convertible Debt of $0 for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2026-07-28
- Tilray Brands, Inc. repayments of convertible debt for the quarter ending 2026-05-31 was $0.00.
- Tilray Brands, Inc. repayments of convertible debt for the quarter ending 2026-02-28 was $0.00.
- Tilray Brands, Inc. repayments of convertible debt for the quarter ending 2025-11-30 was $0.00.
- Tilray Brands, Inc. repayments of convertible debt for the quarter ending 2025-08-31 was $0.00, a 100.00% decline year-over-year.
- Tilray Brands, Inc. repayments of convertible debt for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- Tilray Brands, Inc. repayments of convertible debt for fiscal 2025 was $330.00K, a 99.69% decline from fiscal 2024.
- Tilray Brands, Inc. repayments of convertible debt for fiscal 2024 was $107.33M, a 42.72% decline from fiscal 2023.
- Tilray Brands, Inc. repayments of convertible debt for fiscal 2023 was $187.39M, a 112.88% increase from fiscal 2022.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2026-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $0.00 derived: sum of 2 quarters · filed 2026-07-28 | $0.00 derived: sum of 3 quarters · filed 2026-07-28 | $0.00 10-K · filed 2026-07-28 |
| 2026-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $0.00 derived: sum of 2 quarters · filed 2026-04-01 | $0.00 10-Q · filed 2026-04-01 | $0.00 derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $0.00 10-Q · filed 2026-01-08 | $0.00 derived: sum of 3 quarters · filed 2026-07-28 | $0.00 derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-08-31 | $0.00 10-Q · filed 2025-10-09 | $0.00 derived: sum of 2 quarters · filed 2026-07-28 | $0.00 derived: sum of 3 quarters · filed 2026-07-28 | $0.00 derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $0.00 derived: sum of 2 quarters · filed 2026-07-28 | $0.00 derived: sum of 3 quarters · filed 2026-07-28 | $330.00K 10-K · filed 2026-07-28 |
| 2025-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $0.00 derived: sum of 2 quarters · filed 2026-04-01 | $330.00K 10-Q · filed 2026-04-01 | $330.00K derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $330.00K 10-Q · filed 2026-01-08 | $330.00K derived: sum of 3 quarters · filed 2026-07-28 | $330.00K derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $330.00K 10-Q · filed 2025-10-09 | $330.00K derived: sum of 2 quarters · filed 2026-07-28 | $330.00K derived: sum of 3 quarters · filed 2026-07-28 | $107.66M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $0.00 derived: sum of 2 quarters · filed 2026-07-28 | $107.33M derived: sum of 3 quarters · filed 2026-07-28 | $107.33M 10-K · filed 2026-07-28 |
| 2024-02-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08 | $107.33M derived: sum of 2 quarters · filed 2025-04-08 | $107.33M 10-Q · filed 2025-04-08 | $294.72M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | $107.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10 | $107.33M 10-Q · filed 2025-01-10 | $294.72M derived: sum of 3 quarters · filed 2025-07-29 | $245.75M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | $0.00 10-Q · filed 2024-10-10 | $187.39M derived: sum of 2 quarters · filed 2025-07-29 | $138.42M derived: sum of 3 quarters · filed 2025-07-29 | |
| 2023-05-31 | $187.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $138.42M derived: sum of 2 quarters · filed 2025-07-29 | $187.39M 10-K · filed 2025-07-29 | |
| 2023-02-28 | -$48.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $0.00 10-Q · filed 2024-04-09 | ||
| 2022-11-30 | $48.98M 10-Q · filed 2024-01-09 | |||
| 2022-05-31 | $88.03M 10-K · filed 2024-07-30 | |||
| 2021-05-31 | $0.00 10-K · filed 2023-07-26 | |||
| 2020-05-31 | $812.00K 10-K · filed 2022-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |